Misoprostol

Generic Name
Misoprostol
Brand Names
Arthrotec, Cytotec, Mifegymiso
Drug Type
Small Molecule
Chemical Formula
C22H38O5
CAS Number
59122-46-2
Unique Ingredient Identifier
0E43V0BB57
Background

Misoprostol is a prostaglandin analog used to reduce the risk of NSAID related ulcers, manage miscarriages, prevent post partum hemorrhage, and also for first trimester abortions. The stimulation of prostaglandin receptors in the stomach reduces gastric acid secretion, while stimulating these receptors in the uterus and cervix can increase the strength and f...

Indication

Misoprostol is indicated as a tablet to reduce the risk of NSAID induced gastric ulcers but not duodenal ulcers in high risk patients. Misoprostol is also formulated in combination with diclofenac to treat symptoms of osteoarthritis or rheumatoid arthritis in patients with a high risk of developing gastric ulcers. Misoprostol is used off label for the manage...

Associated Conditions
Gastric Ulcer, Incomplete Abortion, Missed Abortion, Postpartum Haemorrhage (PPH)
Associated Therapies
Induction of cervix ripening therapy, Medically induced abortion

Use Misoprostol to Optimize Prevention of Cervical Cancer

Not Applicable
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-11-01
Last Posted Date
2024-12-05
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
420
Registration Number
NCT06669533
Locations
🇨🇲

Cameroon Baptist Convention Health Core, EtougEbe Baptist Hospital Yaoundé, Yaoundé, Center Region, Cameroon

Mifepristone vs Misoprostol

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2024-07-16
Last Posted Date
2024-11-08
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
94
Registration Number
NCT06502158
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Letrozole and Misoprostol for Early Pregnancy Loss Management

First Posted Date
2024-06-11
Last Posted Date
2024-08-29
Lead Sponsor
University of Pennsylvania
Target Recruit Count
30
Registration Number
NCT06452719
Locations
🇺🇸

PEACE / Penn Medicine, Philadelphia, Pennsylvania, United States

Comparative Study Between the Roles of Intrauterine Misoprostol Versus the Sublingual Route for Prevention of Postpartum Blood Loss in Elective Cesarean Sections

Phase 1
Completed
Conditions
Interventions
First Posted Date
2024-04-15
Last Posted Date
2024-04-15
Lead Sponsor
Cairo University
Target Recruit Count
192
Registration Number
NCT06364098
Locations
🇪🇬

Faculty of medicine, Kasr Alainy, Cairo, Al Manyal, Egypt

Evaluation of Telemedicine Medical Abortion Service in Ecuador

Recruiting
Conditions
Interventions
First Posted Date
2024-02-21
Last Posted Date
2024-10-15
Lead Sponsor
Gynuity Health Projects
Target Recruit Count
100
Registration Number
NCT06270056
Locations
🇪🇨

El Comité de Derechos Sexuales y Reproductivos de Ecuador (CODESER), Ambato, Ecuador

🇪🇨

Cemoplaf, Quito, Ecuador

🇪🇨

Federación Nacional de Obstetrices y Obstetras del Ecuador (FENOE), Quito, Ecuador

Different Medications to Induce Labor

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2024-02-14
Last Posted Date
2024-08-05
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
300
Registration Number
NCT06259097
Locations
🇺🇸

Mount Sinai Hospital, New York, New York, United States

Induction of Labor in Morbidly Obese Patients

Early Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2024-01-10
Last Posted Date
2024-08-16
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
162
Registration Number
NCT06199154
Locations
🇺🇸

University of Maryland Medical Center, Baltimore, Maryland, United States

Effect of Maternal Age and BMI on Induction of Labor Using Oral Misoprostol in Late-term Pregnancies: a Retrospective Cross-sectional Study

First Posted Date
2023-12-28
Last Posted Date
2023-12-28
Lead Sponsor
University of Palermo
Target Recruit Count
104
Registration Number
NCT06184139
Locations
🇮🇹

Andrea Etrusco, Palermo, Italy

Comparative Study Between Preoperative and Postoperative Rectal Misoprostol

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2023-09-21
Last Posted Date
2024-08-20
Lead Sponsor
Egymedicalpedia
Target Recruit Count
128
Registration Number
NCT06049160
Locations
🇪🇬

Faculty of medicine, Cairo University, Cairo, Egypt

Methods Decreasing Bleeding in Open Myomectomy

First Posted Date
2023-04-10
Last Posted Date
2023-04-10
Lead Sponsor
Cairo University
Target Recruit Count
105
Registration Number
NCT05806307
Locations
🇪🇬

faculty of medicine, Kasr el ainy hospital, Cairo university, Cairo, Egypt

© Copyright 2024. All Rights Reserved by MedPath